Stay updated on CD19/CD20/CD22 Triple-targeted Cell Clinical Trial
Sign up to get notified when there's something new on the CD19/CD20/CD22 Triple-targeted Cell Clinical Trial page.

Latest updates to the CD19/CD20/CD22 Triple-targeted Cell Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page’s interface revision number has been updated from version v3.5.2 to v3.5.3, reflecting a site software/release update rather than a modification to the trial record.SummaryDifference0.1%

- Check25 days agoChange DetectedNew revision v3.5.2 added; revision v3.5.0 removed.SummaryDifference0.1%

- Check54 days agoChange DetectedNew revision entry v3.5.0 was added and revision v3.4.3 was removed.SummaryDifference0.1%

- Check61 days agoChange DetectedRevision history updated to include Revision: v3.4.3 and remove Revision: v3.4.2.SummaryDifference0.1%

- Check90 days agoChange DetectedA new revision entry (Revision: v3.4.2) was added and the previous revision (Revision: v3.4.1) was removed from the record history, updating the version list for the study.SummaryDifference0.1%

- Check97 days agoChange DetectedThe record history shows the addition of a new revision entry: Revision v3.4.1, and the deletion of Revision v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to CD19/CD20/CD22 Triple-targeted Cell Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CD19/CD20/CD22 Triple-targeted Cell Clinical Trial page.